Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells

Breast Cancer Research and Treatment

Volumn 42, Issue 1, 1997, Pages 73-81

  Huang, Yue ^b   Ray, Swapan ^b   Reed, John C ^b   Ibrado, Ana Maria ^a   Tang, Caroline ^a   Nawabi, Amir ^a   Bhalla, Kapil ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Apoptosis; Bax; Bcl 2; Breast cancer; Estradiol; Taxol

Indexed keywords

ESTROGEN; PACLITAXEL; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CYTOTOXICITY; ESTROGEN THERAPY; GENE EXPRESSION; GENITAL SYSTEM; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; ONCOGENE C MYC; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; DNA FRAGMENTATION; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN ANTAGONISTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PACLITAXEL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0031018983     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005777219997     Document Type: Article

References (34)

1. Dickson RB, Lippman E: Estrogenic regulation of growth and polypeptide growth factor secretion in breast carcinoma. Endocrine Rev 8: 29-43, 1987
2. Dubik D, Dembinski T, Shiu PC: Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 47: 6517-6521, 1987
3. Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cells death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162-166, 1991
4. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994
5. Sabourin JC, Martin A, Baruch J, Truc JH, Gompel A, Poitout P: bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 59: 1-6, 1994
6. Gee JMW, Robertson JFR, Ellis IO, Willsher P, McClelland RA, Hoyle HB, Kyme SR, Finlay P, Blamey RW, Nicholson RI: Immunocyto-chemical localization of Bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer 59:619-628, 1994
7. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AV, Frye DK, Hortobagyi GN: Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797-1805, 1991
8. Bhalla K, Huang Y, Ray S, Tang C, Ibrado AM, Holycross M, Nawabi A: Taxol-induced apoptosis in estrogen responsive and unresponsive human breast cancer cells [Abstract]. Proc Am Assoc Cancer Res 36: 2473, 1995
9. Miyashita T, Reed JC: BCL-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81: 151-157, 1993
10. Tang C, Willingham MC, Reed JC, Miyashita T, Ray S, Ponnathpur V, Huang Y, Mahoney ME, Bullock G, Bhalla K: High levels of p26BCL-2oncoproteinn retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia 8:1960-1969, 1994
11. Sambrook J, Fritsch EF, Maniatis T: Detection and analysis of protein expressed from cloned genes. In: Molecular Cloning: A Laboratory Manual, 2nd Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor NY, 1989, pp 1869-1871
12. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994
13. Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, Reed JC: Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res 54: 5501-5507, 1994
14. Cohen GM, Xun X-M, Fearnhead H, MacFarlane M, Brown DG, Snowden RT, Dinsdale D: Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J Immunol 153: 507-516, 1994
15. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M: Apoptotic death in epithelial cells: cleavage of DNA to 200 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 36789-3684, 1993
16. Sladowski D, Steer SJ, Clothier RH, Balls M: An improved MTT assay. J Immun Methods 157: 203-207, 1993
17. Buekhurst P, Lowenberg B, Sonneveld P: Enhanced chemosensitivity in acute myeloid leukemia by hemopoietic growth factors: a comparison of the MTT assay with a clonogenic assay. Leukemia 7: 1637-1644, 1944
18. Halachmi S, Murden E, Martin G, MacKay H, Abbondanza C, Brown M: Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264: 1465-1458, 1994
19. Boise L, Gonzalez-Garcia M, Postema C, Ding L, Lindsten T, Turka L, Mao X, Nunex G, Thompson C: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993
20. L by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth & Differ 6: 363-370, 1995
21. Bissonnette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554, 1992
22. Wang TTY, Phang JM: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487-2489, 1995
23. Teixeira C, Reed JC, Pratt MAC: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving BCL-2 proto-oncogene expression in human breast cancer cells. Cancer Res 55: 3902-3907, 1995
24. Bhalla K, Huang Y, Ray S, Tang C, Ibrado AM, Hollycross M, Nawabi A: Taxol-induced apoptosis in estrogen responsive and unresponsive human breast cancer cells [Abstract]. Proc Am Assoc Cancer Res 36: 2473, 1995
25. Seidman AD, Reichman BS, Crown JPA, Yao TJ, Currie V, Hakes TB, Hudis CA, Gilewski TA, Baselga J, Forsythe P, Lepore J, Marks L, Fain K, Souhrada M, Onetto N, Arbuck S, Norton L: Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response. J Clin Oncol 13: 1152-1159, 1995
26. Fornari F, Jarvis W, Grant S, Orr M, Randolph J, White F, Mumaw V, Lovings E, Freeman R, Gewirtz, D: Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin. Cell Growth & Differ 5: 723-733, 1994
27. Bhalla K, Ray S, Huang Y, Tang C, Self S, Mahoney ME, Ponnathpur V, Ibrado AM, Bullock G, Willingham MC: Characterization of a human myeloid leukemia cell line highly resistant to taxol. Leukemia 8: 465-475, 1994
28. Zaman GJR, Flens MJ, VanLeusden MR, DeHaas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci 91: 8822-8826, 1994
29. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993
30. Bhalla K, Tourkina E, Huang Y, Tang C, Mahoney ME, Ibrado AM: Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7: 563-568, 1993
31. Fisher DE, Bodis S, Lowe S, Takemoto C, Housman D, Jacks T: Restoration of apoptosis in p53 deficient tumor cells. Blood 84(10): 430, 1994
32. Sheikh MS, Xiao-Su L, Chen JC, Shao ZM, Ordonez JV, Fontana JA: Mechanisms of regulation WAF1/Cip 1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407-3415, 1994
33. Campos L, Sabido O, Rouault JP, Guyotat D: Effects of bcl-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood 84: 595, 1994
34. Kitada S, Takayama S, DeReil K, Tanaka S, Reed JC: Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res Develop 4: 71-79, 1994